E-LIB Suche - Ergebnisse für: Leary, A

1

21O Coformulated vibostolimab/pembrolizumab in advanced cer..:

Leary, A. ; Yonemori, K. ; Le Tourneau, C....
ESMO Open. 9 (2024) - p. 103521 , 2024

Link: https://doi.org/10.1016/..

2

TECHNICAL MODIFICATION OF ENDOSCOPIC CRANIECTOMY FOR EXAGGE..:

Miller, M. ; Leary, J.
International Journal of Oral and Maxillofacial Surgery. 52 (2024) - p. 36-37 , 2024

Link: https://doi.org/10.1016/..

3

41MO ESR1 mutation in untreated endometrial cancer: Prevale..:

Blanc-Durand, F. ; Nikolaev, S. ; Leman, R....
ESMO Open. 9 (2024) - p. 103541 , 2024

Link: https://doi.org/10.1016/..

4

22O Association of biomarkers with response to coformulated..:

Le Tourneau, C. ; Rojas, C.I. ; Leary, A....
ESMO Open. 9 (2024) - p. 103522 , 2024

Link: https://doi.org/10.1016/..

5

34O ROCSAN: A multicentric randomized phase II/III evaluati..:

Ray-Coquard, I.L. ; Bellesoeur, A. ; Fabbro, M....
ESMO Open. 9 (2024) - p. 103534 , 2024

Link: https://doi.org/10.1016/..

6

A direct geolocation method for aerial imaging surveys of i..:

Rodriguez III, R. ; Jenkins, D. M. ; Leary, J..
International Journal of Environmental Science and Technology. , 2024

Link: https://doi.org/10.1007/..

7

25P Patient-reported outcomes (PROs) with coformulated vibo..:

Yonemori, K. ; Rojas, C.I. ; Leary, A....
ESMO Open. 9 (2024) - p. 103525 , 2024

Link: https://doi.org/10.1016/..

8

46MO What are the predictors of the success of interval deb..:

Marchetti, C. ; Colomban, O. ; Fagotti, A....
ESMO Open. 9 (2024) - p. 103553 , 2024

Link: https://doi.org/10.1016/..

9

Targeting the immune microenvironment in ovarian cancer the..:

Blanc-Durand, F. ; Pautier, P. ; Michels, J..
ESMO Open. 9 (2024) 3 - p. 102936 , 2024

Link: https://doi.org/10.1016/..

10

53P Description of BRCA mutated high-grade ovarian cancer d..:

Leary, A. ; Fouquier, A. ; Ray-Coquard, I.L....
ESMO Open. 9 (2024) - p. 103560 , 2024

Link: https://doi.org/10.1016/..

11

2P Outcomes of patients with gynecological tumors harboring..:

Roussel-Simonin, C. ; Blanc-Durand, F. ; Bayle, A....
ESMO Open. 8 (2023) 1 - p. 100856 , 2023

Link: https://doi.org/10.1016/..

12

OC-0602 Development of an evidence-based adjuvant treatment..:

Vermij, L. ; Putter, H. ; Jobsen, J....
Radiotherapy and Oncology. 182 (2023) - p. S484-S486 , 2023

Link: https://doi.org/10.1016/..

13

34O ATR inhibitor alone (ceralasertib) or in combination wi..:

Banerjee, S. ; Leary, A. ; Stewart, J.R....
ESMO Open. 8 (2023) 1 - p. 100814 , 2023

Link: https://doi.org/10.1016/..

14

Olaparib plus bevacizumab first-line maintenance in ovarian..:

Ray-Coquard, I. ; Leary, A. ; Pignata, S....
Annals of Oncology. 34 (2023) 8 - p. 681-692 , 2023

Link: https://doi.org/10.1016/..

15

Magnetic Anisotropy and Stress-Dependent Epoxy Wetting in F..:

Egbu, J. ; Leary, A. ; Byerly, K....
IEEE Transactions on Magnetics. 59 (2023) 11 - p. 1-9 , 2023

Link: https://doi.org/10.1109/..